ArticleEndocrine2026

Anti-tumour effects of combined lenvatinib and EGFR Inhibition in advanced differentiated thyroid cancer cells.

Ricardo Rodrigues et al.PubMed ↗Publisher ↗

No numbers read from the abstract.